25 August 2022
R&D Center NovaMedica Innotech welcomed finalists of the contest among authors of opinion columns on drug development in Russia Anastasia Novikova, Alexey Veselkov and Maria Lobanova. The contest was organized by the leading website on pharmaceutics GxP News.
Competitors were students of pharmaceutics and medical universities, who needed to write an opinion column on advancement of R&D in Russian pharma. Best works will be published at gxpnews.net, and their authors will be given the status of GxP community experts and will be able to comment on GxP News materials at any time and participate in discussions with opinion leaders of the industry. They will also receive special prizes from the editorial board.
It is great to see the young and bold seize the opportunity to win!
To make sure that the students have a more integrated picture of R&D operations in Russia and of what they can write on next, NovaMedica, at the request of GxP News, invited them for a tour of our R&D Center. CEO of NovaMedica Elena Litvinova and Executive Director of NovaMedica Innotech Yulia Obidchenko were there to help the young authors find out more about pharmaceutical development.
Read more on what our guests saw, what questions they asked and what impressed them in the next issue of GxP News. Until then, below you can find a brief photo spread on the tour.
PrintNovaMedica will produce migraine drug Relonova in Moscow
23 March 2023
A resource for anti-tumor drugs testing has been launched in Russia
23 March 2023
Building a Community of Trust in Epilepsy & Rare Syndromes
23 March 2023
22 March 2023